Filing Details
Genprex, Inc. (NASDAQ:GNPX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:GNPX
Genprex, Inc. (GNPX) Files Quarterly Report for Q0
Genprex, Inc. (NASDAQ:GNPX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Genprex, Inc. (NASDAQ:GNPX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Genprex, Inc. (NASDAQ: GNPX) filed its quarterly report (Form 10-Q) with the SEC on August 14, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.32 with a market capitalization of $5.3 million as a healthcare company.
- The 10-Q filing may contain information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Genprex, Inc.'s stock currently trades at $4.32 with a market capitalization of $5.3M.
The 10-Q provides Genprex, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Genprex, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GNPX Stock Page
Frequently Asked Questions
Where can I read GNPX's SEC filings?
Browse all filings on our GNPX SEC filings page.
What types of SEC filings does Genprex, Inc. file?
Public companies like Genprex, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.